Forest Pharmaceuticals recalls
FDA enforcement reports naming Forest Pharmaceuticals Inc as the recalling firm.
- Recall reports
- 6
- Class I (serious)
- 0
- Most recent report
- Oct 29, 2014
- Oct 29, 2014Bystolic (nebivolol) tablets, 20 mg/tablet, packaged as 7 tablets/bottle/carton, and 12…Drug · Forest Pharmaceuticals IncFailed Dissolution Specification; at the 6-month stability time pointClass II
- Jul 9, 2014Bystolic (nebivolol) tablets, 20 mg/tabletDrug · Forest Pharmaceuticals IncFailed Dissolution Specifications: Drug failed stage III dissolution testing.Class II
- May 28, 2014Bystolic (nebivolol), 20 mg/tablet, 30 tablets per bottle, Rx only, Licensed from Mylan…Drug · Forest Pharmaceuticals IncFailed Dissolution Specifications: One lot of product is being voluntarily recalled because dissolution test results failed to meet specification throughout the product's shelf life.Class II
- Feb 12, 2014Namenda XR (memantine HCl), 7 mg extended release capsules, 30-count bottle, Rx only, F…Drug · Forest Pharmaceuticals IncFailed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.Class III
- Feb 12, 2014Namenda XR (memantine HCl), titration pack (7 mg, 14 mg, 21 mg and 28 mg) extended rele…Drug · Forest Pharmaceuticals IncFailed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.Class III
- Feb 12, 2014Namenda XR (memantine HCl), sample pack, 28 mg, extended release capsules, packaged in…Drug · Forest Pharmaceuticals IncFailed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.Class III